Nanomedicine News

RSS

Nanometric Sensor Identifies Biomarkers of Cancer, Nervous System Diseases

The early diagnosis of certain types of cancer, as well as nervous system diseases such as multiple sclerosis and neuromyelitis optica, may soon be facilitated by the use of a nanometric sensor capable of identifying biomarkers of these pathological conditions.

24 Jun 2015

FDA Authorizes Clinical Trials for AstraZeneca’s Accurin AZD2811 Developed Using Bind Nanomedicine Platform

BIND Therapeutics, Inc., a clinical-stage nanomedicine company developing targeted and programmable therapeutics called Accurins™, today announced that the U.S. Food and Drug Administration (FDA) has authorized the use of AstraZeneca’s Accurin AZD2811 in clinical trials under an investigational new drug (IND) application.

24 Jun 2015

New Wirelessly Controlled Nanowire Implantable Drug-Delivery System

A team of researchers has created a new implantable drug-delivery system using nanowires that can be wirelessly controlled.

24 Jun 2015

Nano-Packaged Drug Can Halt and Reverse Progression of Atherosclerosis in Rodents

In what may be a major leap forward in the quest for new treatments of the most common form of cardiovascular disease, scientists at Johns Hopkins report they have found a way to halt and reverse the progression of atherosclerosis in rodents by loading microscopic nanoparticles with a chemical that restores the animals' ability to properly handle cholesterol.

24 Jun 2015

Scientists Generate 5nm Gold Nanoparticles Radioactively Labeled with Gold Isotope

Nanoparticles are the smallest particles capable of reaching virtually all parts of the body. Researchers use various approaches to test ways in which nanoparticles could be used in medicine - for instance, to deliver substances to a specific site in the body such as a tumor.

23 Jun 2015

Cour's COUR-NP-GLI Bioengineered Nanoparticles Tested in Animal Model of Celiac Disease

Cour Pharmaceutical Development Company today announced new data from a preclinical live animal study demonstrating a breakthrough approach for celiac disease treatment. The data shows a reversal of the effects of dietary gluten exposure, and is being presented during the 16th Annual International Coeliac (Celiac) Disease Symposium being held June 21-24, 2015 in Prague, Czech Republic.

23 Jun 2015

LamdaGen’s ‘Enzymatic Assays for LSPR Based Plasmonic Nano-Sensors’ Receives EPO Allowance

LamdaGen Corporation, a leading developer of diagnostic biosensors, today announced it has received notification from the European Patent Office (EPO) of its intention to grant the patent application entitled "Enzymatic Assays for LSPR" which enables highly sensitive and rapid diagnostic assays.

23 Jun 2015

Benitec Launches New Exploratory Cellular Therapy Program in Collaboration with ReNeuron

Benitec Biopharma is pleased to announce the launch of a new exploratory cellular therapy program including exosome-based delivery utilising the Company's proprietary ddRNAi technology. Entry into these areas have been facilitated by the commencement of a collaboration with UK-based stem cell therapeutics company, ReNeuron.

23 Jun 2015

Experimental Vaccine Candidate eOD-GT8 60mer Could Stimulate Immune System Activity and Stop HIV Infection

New research led by scientists at The Scripps Research Institute (TSRI), International AIDS Vaccine Initiative (IAVI) and The Rockefeller University shows in mice that an experimental vaccine candidate designed at TSRI can stimulate the immune system activity necessary to stop HIV infection. The findings could provide key information for the development of an effective AIDS vaccine.

22 Jun 2015

Tekmira’s TKM-Ebola-Guinea Phase II Clinical Trial Reaches Predefined Statistical Endpoint

Tekmira Pharmaceuticals Corporation, an industry-leading therapeutic solutions company focused on developing a cure for chronic hepatitis B virus infection (HBV), today announced that the Phase II clinical trial of TKM-Ebola-Guinea has reached a predefined statistical endpoint and enrollment has been closed.

22 Jun 2015

Nanomedicine News

Nanometric Sensor Identifies Biomarkers of Cancer, Nervous System Diseases

FDA Authorizes Clinical Trials for AstraZeneca’s Accurin AZD2811 Developed Using Bind Nanomedicine Platform

New Wirelessly Controlled Nanowire Implantable Drug-Delivery System

Nano-Packaged Drug Can Halt and Reverse Progression of Atherosclerosis in Rodents

Scientists Generate 5nm Gold Nanoparticles Radioactively Labeled with Gold Isotope

Cour's COUR-NP-GLI Bioengineered Nanoparticles Tested in Animal Model of Celiac Disease

LamdaGen’s ‘Enzymatic Assays for LSPR Based Plasmonic Nano-Sensors’ Receives EPO Allowance

Benitec Launches New Exploratory Cellular Therapy Program in Collaboration with ReNeuron

Experimental Vaccine Candidate eOD-GT8 60mer Could Stimulate Immune System Activity and Stop HIV Infection

Tekmira’s TKM-Ebola-Guinea Phase II Clinical Trial Reaches Predefined Statistical Endpoint

Laser-Induced Graphene for Printable and Biomedical Applications

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Novel Technique Dramatically Increases Graphene's Elasticity

Cigarette Waste as a Source for Sustainable Supercapacitors

Co-Solvent-Driven Laser Assembly of Gold Nanorods

Breaking Barriers in Thin-Film Deposition with ATLANT 3D’s DALP Technology

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

Sponsored Content

Unlocking Material Behavior at the Microscale Using Nanoindentation

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination